KNTE
Barclays’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,185
| Closed | -$38K | – | 4410 |
|
|
2024
Q1 | $38K | Sell |
14,185
-383
| -3% | -$1.03K | ﹤0.01% | 3875 |
|
|
2023
Q4 | $35K | Hold |
14,568
| – | – | ﹤0.01% | 3888 |
|
|
2023
Q3 | $21K | Hold |
14,568
| – | – | ﹤0.01% | 3899 |
|
|
2023
Q2 | $44K | Sell |
14,568
-14,857
| -50% | -$44.9K | ﹤0.01% | 3736 |
|
|
2023
Q1 | $183K | Buy |
29,425
+5,039
| +21% | +$31.3K | ﹤0.01% | 3204 |
|
|
2022
Q4 | $149K | Buy |
24,386
+8,962
| +58% | +$54.8K | ﹤0.01% | 3250 |
|
|
2022
Q3 | $185K | Sell |
15,424
-228
| -1% | -$2.74K | ﹤0.01% | 3135 |
|
|
2022
Q2 | $197K | Buy |
+15,652
| New | +$197K | ﹤0.01% | 3129 |
|